H-Phe-Gln-Val-Val-Cys(NPys)-Gly-NH2
CAS No. 128102-74-9
H-Phe-Gln-Val-Val-Cys(NPys)-Gly-NH2( ——— )
Catalog No. M39985 CAS No. 128102-74-9
H-Phe-Gln-Val-Val-Cys(NPys)-Gly-NH2
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameH-Phe-Gln-Val-Val-Cys(NPys)-Gly-NH2
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-Phe-Gln-Val-Val-Cys(NPys)-Gly-NH2
-
DescriptionH-Phe-Gln-Val-Val-Cys(NPys)-Gly-NH2
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number128102-74-9
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PZ-2891
PZ-2891 is an orally bioavailable brain penetrant pantothenate kinase (PANK) modulator(hPANK3IC50:1.3 nM).
-
Lingdolinurad
Lingdolinurad is a uric acid transporter protein inhibitor targeting hURAT1 for the study of hyperuricemia or gout.
-
MARK4 inhibitor 1
MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis.?MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.?
Cart
sales@molnova.com